American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
American Journal of Biomedical Research. 2016, 4(1), 5-12
DOI: 10.12691/ajbr-4-1-2
Open AccessArticle

Review of FBN1 Gene Role in Marfan Syndrome Presentations Insilico Analysis

Mohanad Abdelrahim1, 2, , Khalid EL.Khalid3, Mohammed Elamin Faris3, Mohamed A.Hassan2, 4, Kamal Elsiddig5, Ahmed Siddig Muhammed6, Mohammed Nimir7, Mahil Abdalla2 and Asgad Suliman2

1Departement of human anatomy faculty of Medicine University of Khartoum - Sudan

2Daoud research group

3MBBS university of Khartoum

4Division of Molecular Genetics, university of Tubingen,- Germany

5Deprtement of Surgery University of Khartoum - Sudan

6Medical Student University of Khartoum - Sudan

7Institute of endemic diseases - Khartoum - Sudan

Pub. Date: January 18, 2016

Cite this paper:
Mohanad Abdelrahim, Khalid EL.Khalid, Mohammed Elamin Faris, Mohamed A.Hassan, Kamal Elsiddig, Ahmed Siddig Muhammed, Mohammed Nimir, Mahil Abdalla and Asgad Suliman. Review of FBN1 Gene Role in Marfan Syndrome Presentations Insilico Analysis. American Journal of Biomedical Research. 2016; 4(1):5-12. doi: 10.12691/ajbr-4-1-2


Overview: This is translational bioinformatics was focused on analysis of single nucleotide polymorphism of FBN1 gene and reviewing of the previous citations of the damaging SNPs. Introduction: Marfan syndrome is a common autosomal dominant hereditary connective tissue disorder with variable presentations, mutations in FBN1 gene were found to be responsible for Marfan syndrome and other related connective tissue disorders, SNPs contributes to gene mutations and expression variations justifying phenotypic variations among patients and hence such SNPs would be potential target for identification and analysis which may help in early diagnosis of such life threatening disorder. Methods: computational methods were used on this work focusing on analysis of SNPs in the coding regions of FBN1 gene found as non-synonymous variants (ns-SNP) and those in the 3’un-translated regions (3’UTR) affecting miRNA binding using computational methods including SIFT and polyphen for analysis of (nsSNPs), prediction of not previously described SNPs was done using project hope software, while (3’UTR) SNPs was analyzed using PolymiRTS tool functions interactions of FBN1 gene with functionally similar gene were predicted using Genemania software. Results: Out of 1134 ns-SNPs analyzed 38 SNPs were found to damaging while analysis of 175 SNP in 3’UTR prove that 24 SNPs are disturbing to their target sites and 46 SNPs are creating to new target sites.On reviewing of previous citation 31 of the predicted damaging nSNPs were reported as mutations with specific Marfan syndrome presentation while 6 nsSNP were not previously reported with high damaging probability.

marfan syndrome FBN1 gene ns-SNPs 3’UTR SNPs sift polyphene PolymiRTS. project hope Genemania

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  McKusick, Victor A. 'The Defect InMarfan Syndrome'. Nature 352.6333 (1991): 279-281. Web.
[2]  Pyeritz, Reed E., and Victor A. McKusick. 'The Marfan Syndrome: Diagnosis And Management'. New England Journal of Medicine 300.14 (1979): 772-777. Web.
[3]  Corson, Glen M. et al. 'Fibrillin Binds Calcium And Is Coded By Cdnas That Reveal A Multidomain Structure And Alternatively Spliced Exons At The 5′ End'. Genomics 17.2 (1993): 476-484. Web.
[4]  Pereira, L. et al. 'Genomic Organization Of The Sequence Coding For Fibrillin, The Defective Gene Product In Marfan Syndrome'. Hum Mol Genet 2.10 (1993): 1762-1762. Web.
[5]  Biery, Nancy Jensen et al. 'Revised Genomic Organization Offbn1and Significance For Regulated Gene Expression'. Genomics 56.1 (1999): 70-77. Web.
[6]  Hoffjan, S. 'Genetic Dissection OfMarfan Syndrome And Related Connective Tissue Disorders: An Update 2012'. Molecular Syndromology (2012): n. pag. Web.
[7]  Drazen, Jeffrey M. et al.. Nature Genetics 22.2 (1999): 168-170. Web.
[8]  Krawczak, Michael et al. 'Human Gene Mutation Database?A Biomedical Information And Research Resource'. Human Mutation 15.1 (2000): 45-51. Web.
[9]  Sethupathy, Praveen, and Francis S. Collins. 'Microrna Target Site Polymorphisms And Human Disease'. Trends in Genetics 24.10 (2008): 489-497. Web.
[10]  Bhattacharya, A., J. D. Ziebarth, and Y. Cui. 'Polymirts Database 3.0: Linking Polymorphisms In Micrornas And Their Target Sites With Human Diseases And Biological Pathways'. Nucleic Acids Research 42.D1 (2013): D86-D91. Web.
[11]  Ng, P. C., and S. Henikoff. 'Predicting Deleterious Amino Acid Substitutions'. Genome Research 11.5 (2001): 863-874. Web.
[12]  Kupfer, Gary et al. 'A Patient-Derived Mutant Form Of The Fanconi Anemia Protein, FANCA, Is Defective In Nuclear Accumulation'. Experimental Hematology 27.4 (1999): 587-593. Web.
[13]  Kee, Younghoon, and Alan D. D’Andrea. 'Molecular Pathogenesis And Clinical Management Of Fanconi Anemia'. Journal of Clinical Investigation 122.11 (2012): 3799-3806. Web.
[14]  van der Lelij, Petra et al. 'Diagnostic Overlap Between Fanconi Anemia And The Cohesinopathies: Roberts Syndrome And Warsaw Breakage Syndrome'. Anemia 2010 (2010): 1-7. Web.
[15]  Katzke, Stefanie et al. 'TGGE Screening Of The Entire FBN1 Coding Sequence In 126 Individuals With Marfan Syndrome And Related Fibrillinopathies'. Human Mutation 20.3 (2002): 197-208. Web.
[16]  Rommel, Kathrin et al. 'Identification Of 29 Novel And Nine Recurrent Fibrillin-1 (FBN1) Mutations And Genotype-Phenotype Correlations In 76 Patients With Marfan Syndrome'. Human Mutation 26.6 (2005): 529-539. Web.
[17]  Arbustini, Eloisa et al. 'Identification Of Sixty-Two Novel And Twelve Known FBN1 Mutations In Eighty-One Unrelated Probands With Marfan Syndrome And Other Fibrillinopathies'. Human Mutation 26.5 (2005): 494-494. Web.
[18]  Hayward, Caroline, Mary E. Porteous, and David J. H. Brock. 'Mutation Screening Of All 65 Exons Of The Fibrillin-1 Gene In 60 Patients With Marfan Syndrome: Report Of 12 Novel Mutations'. Human Mutation 10.4 (1997): 280-289. Web.
[19]  Loeys, B. 'Genotype And Phenotype Analysis Of 171 Patients Referred For Molecular Study Of The Fibrillin-1 Gene FBN1 Because Of Suspected Marfan Syndrome'. Archives of Internal Medicine 161.20 (2001): 2447-2454. Web.
[20]  Baetens, Machteld et al. 'Applying Massive Parallel Sequencing To Molecular Diagnosis Of Marfan And Loeys-Dietz Syndromes'. Human Mutation 32.9 (2011): 1053-1062. Web.
[21]  Dietz, Harry C. et al. 'Four Novel FBN1 Mutations: Significance For Mutant Transcript Level And EGF-Like Domain Calcium Binding In The Pathogenesis Of MarfanSyndrome'. Genomics 17.2 (1993): 468-475. Web.
[22]  Kainulainen, Katariina et al. 'Mutations In The Fibrillin Gene Responsible For Dominant EctopiaLentis And Neonatal Marfan Syndrome'. Nature Genetics 6.1 (1994): 64-69. Web.
[23]  Hewett, D R et al. 'A New Missense Mutation Of Fibrillin In A Patient With MarfanSyndrome.'. Journal of Medical Genetics 31.4 (1994): 338-339. Web.
[24]  Putnam, Elizabeth A. et al. "Delineation Of The Marfan Phenotype Associated With Mutations In Exons 23–32 Of Thefbn1 Gene". American Journal of Medical Genetics 62.3 (1996): 233-242. Web.
[25]  Montgomery, Robert A. et al. 'Multiple Molecular Mechanisms Underlying Subdiagnostic Variants OfMarfan Syndrome'. The American Journal of Human Genetics 63.6 (1998): 1703-1711. Web.
[26]  El-Aleem, Alice Abd et al. 'Identification Of 9 Novel FBN1 Mutations In German Patients With Marfan Syndrome'. Human Mutation 14.2 (1999): 181-181. Web.
[27]  Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010 Nov 8;11(1):548.
[28]  Mostafavi S, Ray D, Warde-Farley D, Grouios C, Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome biology. 2008;9 Suppl 1:S4.